Results 71 to 80 of about 9,828 (193)

Oral flecainide is effective in management of refractory tachycardia in infants

open access: yesIndian Heart Journal, 2013
Background: Propranolol and digoxin have been used as first line drugs for treatment of supraventricular tachycardia (SVT) in infants. Flecainide and other drugs have been effective as a second line treatment for controlling refractory SVT.
Vikas Kohli
doaj   +1 more source

Arrhythmogenic effect of flecainide toxicity [PDF]

open access: yes, 2013
Flecainide is a class 1C antiarrhythmic drug especially used for the management ofsupraventricular arrhythmia. In overdose cases, flecainide can induce life treating ventriculararrhythmias and cardiogenic shock.
Bonnefoy, Eric   +11 more
core   +1 more source

Flecainide Induced Wide Complex Tachycardia

open access: yes, 2021
Flecainide can increase QRS duration especially with tachycardia (positive use dependence) and organize atrial fibrillation to atrial ...
Zachariah, Shilla
core  

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption

open access: yesCase Reports in Cardiology, 2019
A 67-year-old woman with a history of end-stage renal disease on hemodialysis received a therapeutic dose (150 mg daily) of flecainide for three weeks.
Nicolas De Schryver   +3 more
doaj   +1 more source

Effectiveness and safety of vernakalant vs flecainide for cardioversion of atrial fibrillation in the emergency department: the VERITA study

open access: yesInternational Journal of Emergency Medicine
Background Vernakalant is authorized in several countries, except in the U.S., where the FDA denied its commercialization due to safety concerns, generating debate about its use.
Giuseppe Dominijanni   +5 more
doaj   +1 more source

Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers

open access: yesInternational Journal of Translational Medicine
Background: Intravenous (IV) flecainide is recommended for the pharmacological cardioversion of recent-onset atrial fibrillation (AF). The aim of this study was to study the efficacy and safety of IV flecainide, co-administered with oral b-blockers, for ...
Athanasios Kartalis   +9 more
doaj   +1 more source

Flecainide overdose-induced Brugada electrocardiogram pattern

open access: yes, 2017
A 64-year-old female with paroxysmal atrial fibrillation presented to the emergency department with atrial fibrillation and rapid ventricular rate (Figure 1A), which was refractory to her usual combination doses of ‘pill-in-pocket’ metoprolol (25 mg) and
Greaves, K.   +20 more
core   +1 more source

Safety and tolerability of flecainide for the prevention of atrial fibrillation: A systematic review and meta-analysis

open access: yesКубанский научный медицинский вестник
Background. In the Russian Federation, clinical experience with flecainide remains limited due to its relatively recent regulatory approval. Therefore, it is essential to evaluate the current safety and tolerability of this drug for the prevention of ...
L. V. Polischuk   +3 more
doaj   +1 more source

Flecainide: long-term treatment using a reduced dosing schedule.

open access: yes, 1985
Flecainide was initially prescribed at a dose of 200 mg twice daily, but after early toxicity in patients with ventricular tachycardia (VT), the dosage was reduced to 100 mg twice daily.
Torres, V   +4 more
core   +1 more source

2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines (Part III) on Rate and Rhythm Control in Atrial Fibrillation

open access: yes
Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
Minglong Chen   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy